"Immuron Ltd. isn’t worried about liver toxicity for its NASH treatment, IMM-124E, because the drug acts primarily in the gut to reduce bacteria that promote inflammation seen in the livers of patients with NASH."
$IMRN is featured in an article from this week's BioWorld Insight newsletter on safety concerns for liver treatment. Click below to subscribe.
Liver drug with liver toxicity? Not the best combination
http://www.bioworld.com/content/liver-drug-liver-toxicity-not-best-combination
- Forums
- ASX - By Stock
- Difference between IMM124E and Protectyn?
"Immuron Ltd. isn’t worried about liver toxicity for its NASH...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
8.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.06M |
Open | High | Low | Value | Volume |
8.7¢ | 8.8¢ | 8.7¢ | $10.89K | 124.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4199 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 16280 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11900 | 0.084 |
1 | 50602 | 0.083 |
1 | 40638 | 0.081 |
2 | 88888 | 0.080 |
1 | 7004 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 16280 | 2 |
0.090 | 4450 | 1 |
0.092 | 11000 | 1 |
0.093 | 38095 | 1 |
0.094 | 164287 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online